New data show Shingrix can provide at least 10 years of protection against shingles in adults aged 50 years and over: GSK Ruchika Sharma24 Oct 2022 11:00 AM ISTShingles is caused by the reactivation of the varicella zoster virus (VZV), the same virus that causes chicken pox.
Acyclovir: A Review of its Use in the Management of Shingles Dr. Kamal Kant Kohli14 Sept 2022 12:30 PM ISTHerpes zoster (HZ), commonly known as Shingles, is caused by the reactivation of the varicella-zoster virus (VZV). (1) Often distinguished as a...
Managing Herpes spectrum: "Hit early" and "Hit hard" with antiviral acyclovir dr. Abhimanyu Uppal7 Dec 2021 12:39 PM ISTAn estimated 3.7 billion people under age 50 (67%) have Herpes simplex virus infection (HSV) -1 infection globally. An estimated 491 million people...
Diabetes patients have high risk of developing Herpes Zoster, finds Study Dr. Shravani Dali25 Sept 2021 10:45 AM ISTIndividuals with diabetes mellitus have an increased risk of Herpes Zoster (HZ), suggests a systematic Review and Meta-analysis published in the...
Potential danger to public health: Italy on misuse of Parvulan as COVID treatment Ruchika Sharma11 Sept 2021 4:12 PM ISTMilan: Italy's medicines agency AIFA warned on Friday against the misuse of an unlicensed antiviral drug as a COVID-19 therapy, calling it a potential...
Acyclovir- Exploring the novelty and versatility of an age-old, time-tested antiviral dr. Abhimanyu Uppal9 Aug 2021 12:38 PM ISTAcyclovir is a broad-spectrum antiviral with applications ranging from various herpes infections, chickenpox, shingles and recently its use in HIV...
Vaccine against Herpes Zoster associated with lower incidence of stroke: Study Dr. Shravani Dali17 July 2021 9:15 AM ISTAdministration of ZVL (Zostavax) among Medicare beneficiaries, was linked with lower incidence of stroke, suggests a study published in the Stroke: ...
